Publications

BibTex format

@article{Di:2023:10.1128/msphere.00508-22,
author = {Di, Blasio S and Clarke, M and Hind, CK and Asai, M and Laurence, L and Benvenuti, A and Hassan, M and Semenya, D and Man, DK-W and Horrocks, V and Manzo, G and Van, Der Lith S and Lam, C and Gentile, E and Annette, C and Bosse, J and Li, Y and Panaretou, B and Langford, PR and Robertson, BD and Lam, JKW and Sutton, JM and McArthur, M and Mason, AJ},
doi = {10.1128/msphere.00508-22},
journal = {mSphere},
pages = {1--20},
title = {Bolaamphiphile analogues of 12-bis-THA Cl2 are potent antimicrobial therapeutics with distinct mechanisms of action against bacterial, mycobacterial, and fungal pathogens.},
url = {http://dx.doi.org/10.1128/msphere.00508-22},
volume = {8},
year = {2023}
}

Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - 12-Bis-THA Cl2 [12,12'-(dodecane-1,12-diyl)-bis-(9-amino-1,2,3,4-tetrahydroacridinium) chloride] is a cationic bolalipid adapted from dequalinium chloride (DQC), a bactericidal anti-infective indicated for bacterial vaginosis (BV). Here, we used a structure-activity-relationship study to show that the factors that determine effective killing of bacterial, fungal, and mycobacterial pathogens differ, to generate new analogues with a broader spectrum of activity, and to identify synergistic relationships, most notably with aminoglycosides against Acinetobacter baumannii and Pseudomonas aeruginosa, where the bactericidal killing rate was substantially increased. Like DQC, 12-bis-THA Cl2 and its analogues accumulate within bacteria and fungi. More hydrophobic analogues with larger headgroups show reduced potential for DNA binding but increased and broader spectrum antibacterial activity. In contrast, analogues with less bulky headgroups and stronger DNA binding affinity were more active against Candida spp. Shortening the interconnecting chain, from the most lipophilic twelve-carbon chain to six, improved the selectivity index against Mycobacterium tuberculosis in vitro, but only the longer chain analogue was therapeutic in a Galleria mellonella infection model, with the shorter chain analogue exacerbating the infection. In vivo therapy of Escherichia coli ATCC 25922 and epidemic methicillin-resistant Staphylococcus aureus 15 (EMRSA-15) infections in Galleria mellonella was also achieved with longer-chain analogues, as was therapy for an A. baumannii 17978 burn wound infection with a synergistic combination of bolaamphiphile and gentamicin. The present study shows how this class of bolalipids may be adapted further to enable a wider range of potential applications. IMPORTANCE While we face an acute threat from antibiotic resistant bacteria and a lack of new classes of antibiotic, there are many effective antimicrobials which have limited application due to concerns regar
AU  - Di,Blasio S
AU  - Clarke,M
AU  - Hind,CK
AU  - Asai,M
AU  - Laurence,L
AU  - Benvenuti,A
AU  - Hassan,M
AU  - Semenya,D
AU  - Man,DK-W
AU  - Horrocks,V
AU  - Manzo,G
AU  - Van,Der Lith S
AU  - Lam,C
AU  - Gentile,E
AU  - Annette,C
AU  - Bosse,J
AU  - Li,Y
AU  - Panaretou,B
AU  - Langford,PR
AU  - Robertson,BD
AU  - Lam,JKW
AU  - Sutton,JM
AU  - McArthur,M
AU  - Mason,AJ
DO  - 10.1128/msphere.00508-22
EP  - 20
PY  - 2023///
SN  - 2379-5042
SP  - 1
TI  - Bolaamphiphile analogues of 12-bis-THA Cl2 are potent antimicrobial therapeutics with distinct mechanisms of action against bacterial, mycobacterial, and fungal pathogens.
T2  - mSphere
UR  - http://dx.doi.org/10.1128/msphere.00508-22
UR  - https://www.ncbi.nlm.nih.gov/pubmed/36511707
UR  - https://journals.asm.org/doi/10.1128/msphere.00508-22
UR  - http://hdl.handle.net/10044/1/101661
VL  - 8
ER  -

Download

DrJanineBosse

Contact

Location

Summary

Citation

BibTex format

RIS format (EndNote, RefMan)